Proteolix is Biotechnology in United States that focus on target protein degradation business. Founded in 2003. They cover business area such as operator, target protein degradation, cancer, autoimmune disease, highly specific proteasome inhibitor, safety, efficacy, multiple myeloma, a pipeline, novel proteasome inhibitor, an oral proteasome inhibitor, doctor.
2003
( 21 years old in 2024 )
Target Protein Degradation
-
333 Allerton Avenue
South San Francisco, CA 94080
United States
Private
operatortarget protein degradationcancerautoimmune diseasehighly specific proteasome inhibitorsafetyefficacymultiple myelomaa pipelinenovel proteasome inhibitoran oral proteasome inhibitordoctor
* We use standard office opening hours in near Proteolix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Proteolix is Biotechnology business from United States that founded in 2003 (21 years old in 2024), Proteolix business is focusing on Target Protein Degradation.
Proteolix headquarter office and corporate office address is located in 333 Allerton Avenue South San Francisco, CA 94080 United States.
Proteolix was founded in United States.
In 2024, Proteolix is currently focus on target protein degradation sector.
Above is snippet of Google Trends for "target protein degradation" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Proteolix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
